Effects of (-)-epigallocatechin gallate on rpe cell migration and adhesion

Molecular Vision

Volumn 16, Issue , 2010, Pages 586-595

  Chan, Chi Ming ^a,b   Huang, Jheng Hua ^a,c   Chiang, Han Sun ^a   Wu, Wen Bin ^a   Lin, Hsin Huang ^a   Hong, Jing Yin ^d   Hung, Chi Feng ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2',7' BIS(CARBOXYETHYL) 5(6') CARBOXYFLUORESCEIN ACETOXYMETHYL ESTER; EPIGALLOCATECHIN GALLATE; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; REAGENT; UNCLASSIFIED DRUG; ACTIN; CATECHIN; DRUG DERIVATIVE; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR BB;

ARTICLE; CELL ADHESION; CELL ASSAY; CELL MIGRATION; CONTROLLED STUDY; CYTOSKELETON; ELECTRIC CELL SUBSTRATE IMPEDANCE SENSING MIGRATION ASSAY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INHIBITION KINETICS; MIGRATION INHIBITION; MOLECULAR INTERACTION; PIGMENT CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSWELL MIGRATION ASSAY; WESTERN BLOTTING; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; IMPEDANCE; METABOLISM; PHOSPHORYLATION; TIME;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTINS; CATECHIN; CELL ADHESION; CELL MOVEMENT; CYTOSKELETON; ELECTRIC IMPEDANCE; EPITHELIAL CELLS; FIBRONECTINS; HUMANS; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RETINAL PIGMENT EPITHELIUM; TIME FACTORS;

EID: 77952309629     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Campochiaro PA. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 1997; 115:237-241. [PMID: 9046259]
2. Esser P, Heimann K, Bartz-schmidt KU, Fontana A, Schraermeyer U, Thumann G, Weller M. Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. Exp Eye Res 1997; 65:365-378. [PMID: 9299173]
3. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci 1986; 27:1644-1652. [PMID: 2429937]
4. Abe T, Durlu YK, Tamai M. The properties of retinal pigment epithelial cells in proliferative vitreoretinopathy compared with cultured retinal pigment epithelial cells. Exp Eye Res 1996; 63:201-210. [PMID: 8983978]
5. Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC. Cytokines in proliferative vitreoretinopathy. Eye 1991; 5:686-693. [PMID: 1800167]
6. Kenarova B, Voinov L, Apostolov C, Vladimirova R, Misheva A. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment. Eur J Ophthalmol 1997; 7:64-67. [PMID: 9101198]
7. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci 1995; 36:391-405. [PMID: 7531185]
8. Casaroli-Marano RP, Pagan R, Vilaro S. Epithelialmesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1999; 40:2062-2072. [PMID: 10440262]
9. Ando A, Ueda M, Uyama M, Masu Y, Ito S. Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Br J Ophthalmol 2000; 84:1306-1311. [PMID: 11049960]
10. Hiscott P, Gray R, Grierson I, Gregor Z. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol 1994; 78:219-222. [PMID: 7511932]
11. Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 2006; 58:353-363. [PMID: 16845209]
12. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Agerelated macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48:257-293. [PMID: 12745003]
13. Ball SG, Shuttleworth CA, Kielty CM. Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med 2007; 11:1012-1030. [PMID: 17979880]
14. Kaven CW, Spraul CW, Zavazava NK, Lang GK, Lang GE. Growth factor combinations modulate human retinal pigment epithelial cell proliferation. Curr Eye Res 2000; 20:480-487. [PMID: 10980660]
15. Cui JZ, Chiu A, Maberley D, Ma P, Samad A, Matsubara JA. Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy. Eye 2007; 21:200-208. [PMID: 16531976]
16. Campochiaro PA, Hackett SF, Vinores SA, Freund J, Csaky C, LaRochelle W, Henderer J, Johnson M, Rodriguez IR, Friedman Z, Derevjanik N, Dooner J. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci 1994; 107:2459-2469. [PMID: 7844163]
17. Spraul CW, Kaven C, Lang GK, Lang GE. Effect of growth factors on bovine retinal pigment epithelial cell migration and proliferation. Ophthalmic Res 2004; 36:166-171. [PMID: 15103208]
18. Lei H, Hovland P, Velez G, Haran A, Gilbertson D, Hirose T, Kazlauskas A. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2007; 48:2335-2342. [PMID: 17460299]
19. Li R, Maminishkis A, Wang FE, Miller SS. PDGF-C and-D induced proliferation/migration of human RPE is abolished by inflammatory cytokines. Invest Ophthalmol Vis Sci 2007; 48:5722-5732. [PMID: 18055825]
20. Chan CM, Huang JH, Lin HH, Chiang HS, Chen BH, Hong JY, Hung CF. Protective effects of (-)-epigallocatechin gallate on UVA-induced damage in ARPE19 cells. Mol Vis 2008; 14:2528-2534. [PMID: 19119326]
21. Peng PH, Ko ML, Chen CF. Epigallocatechin-3-gallate reduces retinal ischemia/reperfusion injury by attenuating neuronal nitric oxide synthase expression and activity. Exp Eye Res 2008; 86:637-646. [PMID: 18289530]
22. Hazgui S, Bonnomet A, Nawrocki-Raby B, Milliot M, Terryn C, Cutrona J, Polette M, Birembaut P, Zahm JM. Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells. Respir Res 2008; 9:33. [PMID: 18426555]
23. Park G, Yoon BS, Moon JH, Kim B, Jun EK, Oh S, Kim H, Song HJ, Noh JY, Oh C, You S. Green tea polyphenol epigallocatechin-3-gallate suppresses collagen production and proliferation in keloid fibroblasts via inhibition of the STAT3-signaling pathway. J Invest Dermatol 2008; 128:2429-2441. [PMID: 18463684]
24. Lim YC, Park HY, Hwang HS, Kang SU, Pyun JH, Lee MH, Choi EC, Kim CH. Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett 2008; 271:140-152. [PMID: 18632202]
25. Punathil T, Tollefsbol TO, Katiyar SK. EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem Biophys Res Commun 2008; 375:162-167. [PMID: 18692479]
26. Zhang Y, Han G, Fan B, Zhou Y, Zhou X, Wei L, Zhang J. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity. Eur J Pharmacol 2009; 606:172-179. [PMID: 19171136]
27. Kushima Y, Iida K, Nagaoka Y, Kawaratani Y, Shirahama T, Sakaguchi M, Baba K, Hara Y, Uesato S. Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biol Pharm Bull 2009; 32:899-904. [PMID: 19420761]
28. Zhu J, Wang O, Ruan L, Hou X, Cui Y, Wang JM, Le Y. The tea polyphenol (-)-epigallocatechin 3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int Immunopharmacol 2009; 9:1126-1130. [PMID: 19426837]
29. Kaufmann R, Henklein P, Settmacher U. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation. Oncol Rep 2009; 21:1261-127. [PMID: 19360302]
30. Chae YJ, Kim CH, Ha TS, Hescheler J, Ahn HY, Sachinidis A. Epigallocatechin-3-O-gallate inhibits the angiotensin IIinduced adhesion molecule expression in human umbilical vein endothelial cell via inhibition of MAPK pathways. Cell Physiol Biochem 2007; 20:859-866. [PMID: 17982268]
31. Lo HM, Hung CF, Huang YY, Wu WB. Tea polyphenols inhibit rat vascular smooth muscle cell adhesion and migration on collagen and laminin via interference with cell-ECM interaction. J Biomed Sci 2007; 14:637-645. [PMID: 17436062]
32. Melgarejo E, Medina MA, Sánchez-Jiménez F, Botana LM, Domínguez M, Escribano L, Orfao A, Urdiales JL. (-)-Epigallocatechin-3-gallate interferes with mast cell adhesiveness, migration and its potential to recruit monocytes. Cell Mol Life Sci 2007; 64:2690-2701. [PMID: 17878996]
33. Sen T, Moulik S, Dutta A, Choudhury PR, Banerji A, Das S, Roy M, Chatterjee A. Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7. Life Sci 2009; 84:194-204. [PMID: 19105967]
34. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996; 84:359-369. [PMID: 8608589]
35. Saika S, Yamanaka O, Ikeda K, Kim-Mitsuyama S, Flanders KC, Yoo J, Roberts AB, Nishikawa-Ishida I, Ohnishi Y, Muragaki Y, Ooshima A. Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab Invest 2005; 85:838-850. [PMID: 15924151]
36. Chiang HS, Wu WB, Fang JY, Chen DF, Chen BH, Huang CC, Chen YT, Hung CF. Lycopene inhibits PDGF-BB-induced signaling and migration in human dermal fibroblasts through interaction with PDGF-BB. Life Sci 2007; 81:1509-1517. [PMID: 17950366]
37. Hung CF, Huang TF, Chiang HS, Wu WB. (-)-Epigallocatechin-3-gallate, a polyphenolic compound from green tea, inhibits fibroblast adhesion and migration throughmultiple mechanisms. J Cell Biochem 2005; 96:183-197. [PMID: 16052524]
38. Hughes AD, Clunn GF, Refson J, Demoliou-Mason C. Plateletderived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen Pharmacol 1996; 27:1079-1089. [PMID: 8981052]
39. Hollborn M, Bringmann A, Faude F, Wiedemann P, Kohen L. Signaling pathways involved in PDGF-evoked cellular responses in human RPE cells. Biochem Biophys Res Commun 2006; 344:912-919. [PMID: 16631611]
40. Kirchhof B, Kirchhof E, Ryan SJ, Sorgente N. Human retinal pigment epithelial cell cultures: phenotypic modulation by vitreous and macrophages. Exp Eye Res 1988; 47:457-463. [PMID: 3181329]
41. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 1999; 18:167-190. [PMID: 9932282]
42. Nagineni CN, Samuel W, Nagineni S, Pardhasaradhi K, Wiggert B, Detrick B, Hooks JJ. Transforming growth factorbeta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. J Cell Physiol 2003; 197:453-462. [PMID: 14566975]
43. Cassidy L, Barry P, Shaw C, Duffy J, Kennedy S. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 1998; 82:181-185. [PMID: 9613386]
44. Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 1995; 14:1045-1053. [PMID: 8585935]
45. Carrington L, McLeod D, Boulton M. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction. Invest Ophthalmol Vis Sci 2000; 41:1210-1216. [PMID: 10752962]
46. Choudhury P, Chen W, Hunt RC. Production of platelet-derived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. Invest Ophthalmol Vis Sci 1997; 38:824-833. [PMID: 9112977]
47. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1990; 31:839-846. [PMID: 2186011]
48. Campochiaro PA, Sugg R, Grotendorst G, Hjelmeland LM. Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. Exp Eye Res 1989; 49:217-227. [PMID: 2767169]
49. Robbins SG, Mixon RN, Wilson DJ, Hart CE, Robertson JE, Westra I, Planck SR, Rosenbaum JT. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 1994; 35:3649-3663. [PMID: 8088954]
50. Cui J, Lei H, Samad A, Basavanthappa S, Maberley D, Matsubara J, Kazlauskas A. PDGF receptors are activated in human epiretinal membranes. Exp Eye Res 2009; 88:438-444. [PMID: 19032953]
51. Tingstrom A, Heldin CH, Rubin K. Regulation of fibroblastmediated collagen gel contraction by platelet-derived growth factor, interleukin-1 alpha and transforming growth factorbeta 1. J Cell Sci 1992; 102:315-322. [PMID: 1400635]
52. Smith-Thomas L, Richardson P, Parsons MA, Rennie IG, Benson M, MacNeil S. Additive effects of extra cellular matrix proteins and platelet derived mitogens on human retinal pigment epithelial cell proliferation and contraction. Curr Eye Res 1996; 15:739-748. [PMID: 8670782]
53. Mori K, Gehlbach P, Ando A, Dyer G, Lipinsky E, Chaudhry AG, Hackett SF, Campochiaro PA. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Invest Ophthalmol Vis Sci 2002; 43:2001-2006. [PMID: 12037011]
54. Chan CM, Fang JY, Lin HH, Yang CY, Hung CF. Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K Akt and MAPK pathways. Biochem Biophys Res Commun 2009; 388:172-176. [PMID: 19664603]
55. Lo HM, Hung CF, Tseng YL, Chen BH, Jian JS, Wu WB. Lycopene binds PDGF-BB and inhibits PDGF-BB-induced intracellular signaling transduction pathway in rat smooth muscle cells. Biochem Pharmacol 2007; 74:54-63. [PMID: 17449016]
56. Ikuno Y, Leong FL, Kazlauskas A. PI3K and PLCgamma play a central role in experimental PVR. Invest Ophthalmol Vis Sci 2002; 43:483-489. [PMID: 11818394]
57. Rosenkranz S, DeMali KA, Gelderloos JA, Bazenet C, Kazlauskas A. Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis. J Biol Chem 1999; 274:28335-28343. [PMID: 10497192]
58. Hinton DR, He S, Graf K, Yang D, Hsueh WA, Ryan SJ, Law RE. Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells. Exp Cell Res 1998; 239:11-15. [PMID: 9511719]
59. Krott R, Lebek J, Grisanti S, Esser P, Heimann K. Antiproliferative Wirkung von Genistein auf kultivierte retinale Pigmentepithelzellen vom Schwein. Ophthalmologica 2000; 214:296-300. [PMID: 10859515]
60. Yoon HS, Rho SH, Jeong JH, Yoon S, Yoo KS, Yoo YH. Genistein produces reduction in growth and induces apoptosis of rat RPE-J cells. Curr Eye Res 2000; 20:215-224. [PMID: 10694898]
61. Alge CS, Priglinger SG, Kook D, Schmid H, Haritoglou C, Welge-Lussen U, Kampik A. Galectin-1 influences migration of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2006; 47:415-426. [PMID: 16384992]
62. Troger J, Sellemond S, Kieselbach G, Kralinger M, Schmid E, Teuchner B, Nguyen QA, Schretter-Irschick E, Göttinger W. Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells. Br J Ophthalmol 2003; 87:1403-1408. [PMID: 14609844]
63. Ito S, Sakamoto T, Tahara Y, Goto Y, Akazawa K, Ishibashi T, Inomata H. The effect of tranilast on experimental proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 1999; 237:691-696. [PMID: 10459620]